Slowly absorbed L-dopa preparation in the treatment of parkinsonism.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002250:Carbon Radioisotopes; D003692:Delayed-Action Preparations; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D010300:Parkinson Disease / Q000188:drug therapy*; D011930:Reaction Time; D013997:Time Factors
D002250:Carbon Radioisotopes; D003692:Delayed-Action Preparations; D004295:Dihydroxyphenylalanine